Status:
UNKNOWN
MACS Study - Microparticles and Coagulation in Sickle Cell Disease
Lead Sponsor:
University College, London
Collaborating Sponsors:
Guy's and St Thomas' NHS Foundation Trust
The Whittington Hospital NHS Trust
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
Brief Summary
Sickle cell disease (SCD) is an inherited disorder of the red blood cell. It is now the commonest genetic disorder in the UK and of childhood stroke, with up to 40% of children having a stroke (clinic...
Detailed Description
Purpose and design * Why is it needed? The purpose of this study is to try and identify a measurable parameter to act as a disease indicator in sickle cell disease. The reason such a parameter is nee...
Eligibility Criteria
Inclusion
- Subject
- Patient (or parent if child) able to give informed consent Compound heterozygote or homozygote for a sickling disorder (i.e. has sickle cell disease) Having a blood test in any case
- Healthy volunteer
- Person (or parent if child) able to give informed consent If a child, having a blood test or cannula inserted in any case Ethnically matched - of African origin Must know their sickle cell status or have it tested as part of the study and agree to have this result given to them and their G.P.
Exclusion
- Subject
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01242878
Start Date
December 1 2010
Last Update
November 18 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Whittington Hospital NHS Trust
London, United Kingdom, N19 5NF
2
University College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2PJ
3
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom, SE1 7EH